Mode
Text Size
Log in / Sign up
N/A Completed N=31 Treatment

Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy

X-linked Adrenoleukodystrophy
Source: ClinicalTrials.gov NCT01594853 ↗
Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: Change in Maximal Voluntary Contraction of the Hip Flexors From Baseline to End of Training and to Post-training — 0.94; 0.98; 1.32; 1.37 kg

Summary

The purpose is to see how X-linked adrenoleukodystrophy (X-ALD) is associated with strength and sensation using MRI, in women with X-ALD. The investigators will also see whether exercise can improve these symptoms for women with X-ALD.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Maximal Voluntary Contraction of the Hip Flexors From Baseline to End of Training and to Post-training
0.94; 0.98; 1.32; 1.37

Eligibility Criteria

Inclusion Criteria

  • confirmed diagnosis, X-ALD heterozygote carrier
  • no medical contraindication to participating in a strength training program
  • able to follow complex directions as determined by a score of ≤1 on a subset of questions taken from the NIH Stroke scale (Brott et al. 1989)
  • hip flexion strength: 6.6-15.8kg
  • hip extension strength: up to 18.3 kg
  • normal passive range of motion at hips/knees/ankles
  • able to walk ≥50m

Exclusion Criteria

  • Evidence of other neurological deficit that could interfere, such as previous stroke or muscle disease
  • congestive heart failure
  • cancer
  • orthopedic conditions
  • severe pain that precludes study participation
  • seizures
  • pregnancy
  • other medical condition that precludes participation in an exercise program, e.g., unstable angina, uncontrolled diabetes, uncontrolled hypertension

Healthy controls have the same age and exclusion criteria as women with AMN except that they will not be carriers for X-ALD. They must have normal neurological function.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01594853). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search